Literature DB >> 33906911

Conversion of α-Cells to β-Cells in the Postpartum Mouse Pancreas Involves Lgr5 Progeny.

Uylissa A Rodriguez1, Mairobys Socorro1,2, Angela Criscimanna1, Christina P Martins1, Nada Mohamed1, Jing Hu3, Krishna Prasadan1, George K Gittes1, Farzad Esni4,5,6.   

Abstract

In contrast to the skin and the gut, where somatic stem cells and their niche are well characterized, a definitive pancreatic multipotent cell population in the adult pancreas has yet to be revealed. Of particular interest is whether such cells may be endogenous in patients with diabetes, and if so, can they be used for therapeutic purposes? In the current study, we used two separate reporter lines to target Cre-recombinase expression to the Lgr5- or glucagon-expressing cells in the pancreas. We provide evidence for the existence of a population of cells within and in the proximity of the ducts that transiently express the stem-cell marker Lgr5 during late gestational stages. Careful timing of tamoxifen treatment in Lgr5EGFP-IRES-CreERT2 ;R26 Tomato mice allowed us to show that these Lgr5-expressing progenitor cells can differentiate into α-cells during pregnancy. Furthermore, we report on a spontaneous lineage conversion of α- to β-cells specifically after parturition. The contribution of Lgr5 progeny to the β-cell compartment through an α-cell intermediate phase early after pregnancy appears to be part of a novel mechanism that would counterbalance against excessive β-cell mass reduction during β-cell involution.
© 2021 by the American Diabetes Association.

Entities:  

Year:  2021        PMID: 33906911     DOI: 10.2337/db20-1059

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  1 in total

1.  The Essential Role of Pancreatic α-Cells in Maternal Metabolic Adaptation to Pregnancy.

Authors:  Liping Qiao; Sarah Saget; Cindy Lu; Tianyi Zang; Brianna Dzyuba; William W Hay; Jianhua Shao
Journal:  Diabetes       Date:  2022-05-01       Impact factor: 9.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.